Schonfeld Strategic Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$63.8K Buy
2023
Q4
Sell
2023
Q3
$328K Buy
2023
Q1
Sell
2022
Q4
$263K Sell
2022
Q3
$5.57M Buy
2022
Q1
Sell
2021
Q4
$1.24M Sell
2021
Q3
$2.96M Buy
2021
Q2
$1.85M Buy
2021
Q1
$1.92M Buy